Published in

SAGE Publications, Australian and New Zealand Journal of Psychiatry, 7(39), p. 558-564, 2005

DOI: 10.1080/j.1440-1614.2005.01627.x

SAGE Publications, Australian and New Zealand Journal of Psychiatry, 7(39), p. 558-564

DOI: 10.1111/j.1440-1614.2005.01627.x

Links

Tools

Export citation

Search in Google Scholar

Acute tryptophan depletion. Part I: Rationale and methodology

Journal article published in 2005 by Caroline J. Bell, Sean D. Hood ORCID, David J. Nutt
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Objective: Acute tryptophan depletion (ATD) is an experimental technique that has been widely used over the last decade to investigate the role of serotonin (5-HT) in a variety of disorders. This review, the first of two articles, describes the rationale behind this technique and provides detail on how it is applied in research settings. Method: The authors outline the development of this technique with reference to the seminal literature and more recent findings from neuroimaging and neuroendocrine studies. This is supplemented by the authors' clinical experience of over 5 years of continuous experimental work with this paradigm in over 50 subjects. Results: Acute tryptophan depletion is a method that significantly reduces central 5-HT in human subjects. Non-serotonergic explanations of the effects of ATD have not been confirmed, supporting the specificity of this method. Conclusions: The ATD technique is a valid method of manipulating central 5-HT levels. The second article in this series will review the application of ATD in depression, anxiety and other psychiatric conditions.